ImmunOs
1 known investors
Immunos Therapeutics develops therapies for immuno-oncology and inflammatory diseases. The company focuses on advancing treatments in cancer immunotherapy and inflammation-related conditions.
BiotechHealthtechMedical Devices
Investors · 1
In the news
- ImmunOs Therapeutics AG Raises $11 Million and Further Strengthens Investor Basefinance.yahoo.com · 2024
- ImmunOs Therapeutics Raises $74 Million Series B Financing Roundglobenewswire.com · 2022
- ImmunOs Therapeutics AG Raises CHF 15M in Series A Financing, Co-led by Pfizer Ventures and BioMedPartners, to Advance a Novel Immunotherapy Agent For Cancer Into Human Trials | Business Wirebusinesswire.com · 2019